B. Chertok, A. E. David, and V. C. Yang, Polyethyleneimine-modified iron oxide nanoparticles for brain tumor drug delivery using magnetic targeting and intra-carotid administration, Biomaterials, vol.31, issue.24, pp.6317-6324, 2010.
DOI : 10.1016/j.biomaterials.2010.04.043

I. F. Duarte, Following dynamic biological processes through NMR-based metabonomics: A new tool in nanomedicine?, Journal of Controlled Release, vol.153, issue.1, pp.34-39, 2011.
DOI : 10.1016/j.jconrel.2011.03.008

D. Food, D. Administration, P. Balenzuela, J. Foss, and D. R. Chialvo, Ising-like dynamics in large-scale functional brain networks, www.fda.org Fraiman, Phys Rev E Stat Nonlin Soft Matter Phys, vol.79, pp.8-21, 2009.

K. Likharev, A. Mayr, I. Muckra, and O. Turel, CrossNets: High-Performance Neuromorphic Architectures for CMOL Circuits, Annals of the New York Academy of Sciences, vol.87, issue.226801, pp.146-163, 2003.
DOI : 10.1196/annals.1292.010

S. C. Mcbain, H. H. Yiu, and J. Dobson, Magnetic nanoparticles for gene and drug delivery, Int J Nanomedicine, vol.3, pp.169-180, 2008.

S. M. Moghimi, Bionanotechnologies for treatment and diagnosis of Alzheimer's disease, Nanomedicine: Nanotechnology, Biology and Medicine, vol.7, issue.5, pp.515-518, 2011.
DOI : 10.1016/j.nano.2011.05.001

T. Ohno, T. Hasegawa, T. Tsuruoka, K. Terabe, J. K. Gimzewski et al., Short-term plasticity and long-term potentiation mimicked in single inorganic synapses, Nature Materials, vol.96, issue.8, pp.591-595, 2011.
DOI : 10.1038/nmat3054

V. Palanisamy, S. Sharma, A. Deshpande, H. Zhou, J. Gimzewski et al., Nanostructural and Transcriptomic Analyses of Human Saliva Derived Exosomes, PLoS ONE, vol.64, issue.19, p.8577, 2010.
DOI : 10.1371/journal.pone.0008577.s002

D. Pan, S. D. Carauthers, J. Chen, P. M. Winter, A. Senpan et al., Nanomedicine strategies for molecular targets with MRI and optical imaging, Future Medicinal Chemistry, vol.2, issue.3, pp.471-490, 2010.
DOI : 10.4155/fmc.10.5

W. M. Pardridge, Molecular Trojan horses for blood???brain barrier drug delivery, Current Opinion in Pharmacology, vol.6, issue.5, pp.139-143, 2006.
DOI : 10.1016/j.coph.2006.06.001

M. Pautler and S. Brenner, Nanomedicine: promises and challenges for the future of public health, Int J Nanomedicine, vol.5, pp.803-809, 2010.

C. Roney, P. Kulkarni, V. Arora, P. Antich, F. Bonte et al., Targeted nanoparticles for drug delivery through the blood???brain barrier for Alzheimer's disease, Journal of Controlled Release, vol.108, issue.2-3, pp.193-214, 2005.
DOI : 10.1016/j.jconrel.2005.07.024

O. Sporns, D. R. Chialvo, M. Kaiser, and C. C. Hilgetag, Organization, development and function of complex brain networks, Trends in Cognitive Sciences, vol.8, issue.9, pp.418-425, 2004.
DOI : 10.1016/j.tics.2004.07.008

H. B. Stolp and K. M. Dziegielewska, Review: Role of developmental inflammation and blood-brain barrier dysfunction in neurodevelopmental and neurodegenerative diseases, Neuropathology and Applied Neurobiology, vol.50, issue.2, pp.132-146, 2009.
DOI : 10.1111/j.1365-2990.2008.01005.x

A. Surendiran, S. Sandhiya, S. C. Pradhan, and C. Adithan, Novel applications of nanotechnology in medicine, Indian J Med Res, vol.130, pp.689-701, 2009.

J. Szebeni, [Nanomedicine: application of nanotechnology in medicine. Opportunities in neuropsychiatry], Neuropsychopharmacol Hung, vol.13, pp.15-24, 2011.

V. Wagner, A. Dullaart, A. K. Bock, and A. Zweck, The emerging nanomedicine landscape, Nature Biotechnology, vol.273, issue.10, pp.1211-1217, 2006.
DOI : 10.1517/14712598.1.6.923

URL : http://www.nature.com/nbt/journal/v24/n10/pdf/nbt1006-1211.pdf

J. Wang, J. D. Byrne, M. E. Napier, and J. M. Desimone, More Effective Nanomedicines through Particle Design, Small, vol.23, issue.14, pp.1919-1931, 2011.
DOI : 10.1002/smll.201100442

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3136586